Details of the Drug
General Information of Drug (ID: DMTBYCY)
| Drug Name |
RX-0201N
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | RX-0201-nano; AKT-1 protein kinase inhibitor (oral nanoliposomal formulation, cancer), Rexahn Pharmaceuticals | ||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
